AQST Aquestive Corp: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
Aquestive Therapeutics (AQST) maintains moderate financial stability, as revenue depends on patent rights and new releases. This EV/EBITDA chart with historical data visualizes the valuation trend of enterprise value relative to operating profit, while 0.00 reflects the metric's most recent value. Profit is based on the sale of soluble films for allergy and epilepsy therapy. Experienced management is effectively developing a portfolio of innovative drug delivery systems.
פילוחי מדדים מקיפים ואנליטיקה עבור aquestive.com (AQST)
The specifics of Aquestive Therapeutics (AQST), which depend on stable demand for drugs amid risks of raw material supply chain disruptions, require strict control of debt load. This metric compares the total enterprise value with operating profit, allowing the identification of fundamental asset undervaluation or critical debt levels that determine the company's investment attractiveness through changes in the EV/EBITDA value over time.
